Gonadotropin replacement in male thalassemia major patients with arrested puberty and acquired hypogonadotropic hypogonadism (AAH): preliminary results and potential factors affecting induction of spermatogenesis

Endocrine. 2019 Jan;63(1):167-170. doi: 10.1007/s12020-018-1772-4. Epub 2018 Oct 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Cholecalciferol / therapeutic use
  • Chorionic Gonadotropin / therapeutic use*
  • Hormone Replacement Therapy / methods*
  • Humans
  • Hypogonadism / drug therapy*
  • Hypogonadism / etiology
  • Infertility, Male / drug therapy
  • Infertility, Male / etiology
  • Magnetic Resonance Imaging
  • Male
  • Puberty, Delayed / drug therapy*
  • Puberty, Delayed / etiology
  • Sexual Dysfunction, Physiological / drug therapy
  • Sexual Dysfunction, Physiological / etiology
  • Spermatogenesis / drug effects*
  • Treatment Outcome
  • Vitamins / therapeutic use
  • beta-Thalassemia / complications
  • beta-Thalassemia / diagnostic imaging
  • beta-Thalassemia / drug therapy*

Substances

  • Chorionic Gonadotropin
  • Vitamins
  • Cholecalciferol